Post-COVID-19 Condition in Hospitalized Survivors After 1 Year of Infection During the Alpha- and Delta-variant Dominant Waves in Japan: COVID-19 Recovery Study II
Yoko Muto(National Center for Global Health and Medicine), Hiroyasu Iso(University of Tsukuba), Taku Oshima(Chiba University), Arisa Iba(National Center for Global Health and Medicine), Hideki Yoshida(Kyoto Prefectural University of Medicine), Katsuji Teruya(National Center for Global Health and Medicine), Toshiyuki Harada(Hokkaido hospital), Junji Hatakeyama(Osaka University of Pharmaceutical Sciences), Shinichiro Morioka(National Center for Global Health and Medicine), Nobuyuki Nosaka(Tokyo Medical and Dental University), Shuhei Maruyama(Kansai Medical University), Futoshi Nagashima, Akira Kawauchi(Maebashi Red Cross Hospital), Satoshi Miike(Maebashi Red Cross Hospital), Hayato Taniguchi(Hiroshima University), Mariko Hosozawa(National Center for Global Health and Medicine), Hiroshi Kamijo(Shinshu University Hospital), Hideaki Kato(Yokohama City University Hospital), Tatsuya Fuchigami(University of the Ryukyus University Hospital), Takeshi Hattori(National Hospital Organization Hokkaido Medical Center), Takeshi Nishida(Osaka Prefectural Medical Center), Yuichi Sato(Tokyo Metropolitan Tama Medical Center), Kohei Ota(Hiroshima University), Miyuki Hori(Public Health Department), Shigeki Fujitani(St. Marianna University School of Medicine), Tomohiro Asahi(Naha City Hospital), Kensuke Nakamura(Hitachi General Hospital)
Cited by 4
Related Papers
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
|New England Journal of Medicine|2010|5.6k
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
|Annals of Oncology|2012|555
Two‐component system VraSR positively modulates the regulation of cell‐wall biosynthesis pathway in <i>Staphylococcus aureus</i>
|Molecular Microbiology|2003|520
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study
|Journal of Clinical Oncology|2019|490
Development of Sodium‐Sulfur Batteries
|International Journal of Applied Ceramic Technology|2004|354